市場調査レポート

商品コード

1619333

感染症治療薬の市場規模、シェア、成長分析、タイプ別、治療法別、地域別- 産業予測、2024～2031年

Infectious Disease Therapeutics Market Size, Share, Growth Analysis, By Type (HIV, Hepatitis), By Treatment (Antibacterial, Antifungal Drugs), By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

感染症治療薬の世界市場規模は、2022年に1,168億米ドルと評価され、2023年の1,217億1,000万米ドルから2031年には1,691億4,000万米ドルに成長し、予測期間中（2024年～2031年）のCAGRは4.2％で成長する見通しです。

世界のヘルスケア部門は、ウイルスや細菌を含むさまざまな病原体によって引き起こされる感染症による計り知れない課題に直面し続けています。診断法、治療法、ワクチン接種などの予防策が進歩し、死亡率が低下したにもかかわらず、これらの疾病の再発は依然として公衆衛生上の重大な問題です。その結果、感染率の上昇、早期診断に対する意識の高まり、政府や民間団体による研究資金の増加などを背景に、感染症治療薬の市場は大きな成長を遂げようとしています。しかしながら先進的な治療は高価であるため、多くの患者のアクセスが制限され、市場拡大の課題となっています。さらに、手頃な価格のジェネリック医薬品を好む傾向が強まっており、感染症対策を目的としたブランド治療薬の成長を脅かしています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Gilead Sciences
GlaxoSmithKline（GSK）
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Pfizer Inc.
Novartis AG
Johnson & Johnson（Janssen Pharmaceuticals）
BioCryst Pharmaceuticals Inc.
Boehringer Ingelheim GmbH
AbbVie Inc.
Sanofi
AstraZeneca
Bristol-Myers Squibb（BMS）
Moderna, Inc.
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Vir Biotechnology, Inc.
Eli Lilly and Company
Amgen Inc.

結論と推奨事項

Product Code: SQMIG35J2030

Global Infectious Disease Therapeutics Market size was valued at USD 116.8 billion in 2022 and is poised to grow from USD 121.71 billion in 2023 to USD 169.14 billion by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).

The global healthcare sector continues to face immense challenges due to infectious diseases, which are triggered by a range of pathogens including viruses and bacteria. Despite progress in diagnostics, treatment methods, and preventive measures like vaccinations that have lowered mortality rates, the resurgence of these diseases remains a critical public health issue. Consequently, the infectious disease therapeutics market is poised for considerable growth, driven by rising infection rates, heightened awareness for early diagnosis, and increased funding for research from governmental and private entities. Nonetheless, the expensive nature of advanced treatments poses a challenge for market expansion, limiting access for many patients. Additionally, the growing preference for affordable generic medications threatens the growth of branded therapeutics aimed at combating infectious diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Disease Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Disease Therapeutics Market Segmental Analysis

Global Infectious Disease Therapeutics Market is segmented by type, treatment, end users and region. Based on type, the market is segmented into HIV, hepatitis, influenza, TB, malaria and HPV. Based on treatment, the market is segmented into antibacterial, antifungal drugs, antiviral drugs and others. Based on end users, the market is segmented into hospitals and clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infectious Disease Therapeutics Market

The global infectious disease therapeutics market is likely to experience significant growth due to several driving factors. An increase in investment aimed at improving access to treatments for infectious diseases, along with strategic initiatives to raise awareness regarding both the treatments and diagnostics of these conditions, will contribute positively to market expansion. Furthermore, there has been a noticeable rise in clinical trial research dedicated to the development of innovative pharmaceutical solutions. Collectively, these elements are expected to propel the demand for infectious disease therapeutics, shaping a promising outlook for the market in the coming years.

Restraints in the Global Infectious Disease Therapeutics Market

The growth of the Global Infectious Disease Therapeutics market may be hindered by several factors, particularly the lack of awareness regarding available treatment options. In many developing nations, there is insufficient adoption of these therapies, compounded by limited reimbursement options for specific infectious diseases. This combination of inadequate understanding and accessibility can significantly restrain the market's expansion throughout the projected timeframe, as healthcare providers and patients may not fully utilize or access the innovative treatments necessary to combat these diseases effectively. Consequently, addressing these challenges is crucial for the market to reach its full potential in the coming years.

Market Trends of the Global Infectious Disease Therapeutics Market

The Global Infectious Disease Therapeutics market is witnessing significant growth, driven by the rising prevalence of malaria, particularly in developing regions such as India, Africa, and Southeast Asia. This surge is further fueled by increased research and development efforts from key pharmaceutical manufacturers and healthcare organizations aimed at advancing therapeutic options. Innovations in drug formulations and delivery methodologies, coupled with heightened awareness and funding for infectious disease management, are propelling the market forward. Additionally, strategic collaborations and partnerships in the healthcare sector are expected to enhance access to effective treatments, thereby shaping a robust market landscape in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Infectious Disease Therapeutics Market Size by Type & CAGR (2024-2031)

Market Overview
HIV
Hepatitis
Influenza
TB
Malaria
HPV

Global Infectious Disease Therapeutics Market Size by Treatment & CAGR (2024-2031)

Market Overview
Antibacterial
Antifungal Drugs
Antiviral Drugs
Others

Global Infectious Disease Therapeutics Market Size by End Users & CAGR (2024-2031)

Market Overview
Hospitals
Clinics

Global Infectious Disease Therapeutics Market Size & CAGR (2024-2031)

North America (Type, Treatment, End Users)
- USA
- Canada
Europe (Type, Treatment, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Treatment, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Treatment, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Treatment, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Gilead Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (Janssen Pharmaceuticals)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCryst Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (BMS)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vir Biotechnology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

感染症治療薬の市場規模、シェア、成長分析、タイプ別、治療法別、地域別- 産業予測、2024～2031年

Infectious Disease Therapeutics Market Size, Share, Growth Analysis, By Type (HIV, Hepatitis), By Treatment (Antibacterial, Antifungal Drugs), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

感染症治療薬の市場規模：タイプ別& CAGR（2024-2031）

感染症治療薬の市場規模：治療法別& CAGR（2024-2031）

感染症治療薬の市場規模：エンドユーザー別& CAGR（2024-2031）

感染症治療薬の市場規模：地域別& CAGR（2024-2031）